Skip to content

Acute and delayed effects of THC on memories of stress in healthy adults

Hanna Molla, Evan Hahn, Christian Ramos, Harriet de Wit

Psychopharmacology April 15, 2026 DOI: 10.1007/s00213-026-07064-1 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Double-blind Peer reviewed
Sample size 36
Population Healthy adults aged 18-35 years
Intervention THC
Dose 5 or 10 mg
Duration Three sessions over two weeks
Topics Cannabis
Key findings THC at 5 or 10 mg did not dampen most subjective or physiological responses to stress-related images, except for reducing affective facial expressions. No lasting effects were observed one week later, and Bayes factor analyses supported the null findings.

Abstract

Abstract Rationale Many cannabis users claim that one reason they use cannabis is to relieve stress or dampen effects of stressful memories. However, the processes by which cannabis or its primary constituent, Δ 9 -tetrahydrocannabinol (THC) alleviate stressful experiences remains unclear.

Objective: Here, we assessed whether low oral doses of THC reduce emotional or physiological responses to memories of a standardized social stress procedure in healthy volunteers.

Methods: Healthy adults (18–35 years) received placebo, 5, or 10 mg THC groups ( n = 12 per group) under double-blind conditions before retrieving memories of a stressful event. They participated in three sessions: (1) social stress procedure to establish stress memories, (2) pretreatment with THC or placebo followed by presentation of stress session images, and (3) re-presentation of stress images without drug. During Session 1, participants underwent a Trier Social Stress Test (TSST) and a non-stress control task to create individualized stress and neutral memory images. During Session 2 one week later, participants received THC (5 or 10 mg) or placebo before viewing images from Session 1. Dependent measures included subjective and physiological responses to the stress and control images, during a memory retrieval task. During Session 3, conducted one week after Session 2, image-elicited responses were reassessed without administration of drug.

Results: During the stress memory retrieval on Session 2, the TSST-images significantly increased distress and arousal relative to control images. However, THC (5 and 10 mg) did not dampen most of the subjective or physiological responses to the images. The only measure on which THC reduced responses was on affective facial emotional expressions during presentation of stress images. No lasting effects of the drug were observed on Session 3. Although the small sample raised questions about power, Bayes factor analyses supported the conclusion of null findings.

Conclusions: Using this novel procedure, images established with a social stress procedure elicited stress responses one week later. However, low doses of THC failed to diminish most of the subjective or physiological responses to stress-related images. Future work should examine whether these findings can be replicated in larger samples.

Comparable studies

Other randomized controlled trials on cannabis, most cited first.

Study Year Design Participants
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment Healthy participants 2012 Randomized controlled trial n = 48
Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing Healthy, English-native, right-handed men who had used cannabis 15 times or less in... 2009 Double-blind, randomized, placebo-controlled crossover trial n = 15
Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers Healthy male subjects 2012 Randomized controlled trial n = 16
Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol Healthy, native English-speaking, right-handed men of white race/ethnicity who had used... 2009 Randomized controlled trial n = 15
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition Healthy volunteers with a history of light cannabis use 2019 Randomized, double-blind, within-subjects crossover n = 14

Citations in the library

Explore topics